Live BHI Webinar Event: Emerging Concepts in the Diagnosis and Treatment of Hypothyroidism
Kent Holtorf, M.D.
Wednesday, August 17, 2011
1:15pm EST/10:15am PST
In this installment of our ongoing webinar series, Dr. Holtorf will discuss the latest research, science, and clinical experience related to the detection and treatment of thyroid disorders, including the unreliability of the commonly used TSH to measure tissue levels of thyroid hormones. Dr. Holtorf will describe the symptoms of hypothyroidism, including fatigue, depression, weight gain, heart disease and early mortality, and will outline integrative treatment modalities and clinical case studies.
About Kent Holtorf, M.D.
He is the medical director of the Holtorf Medical Group Affiliate Centers, the medical director of the non-profit National Academy of Hypothyroidism and was the founding medical director for Fibromyalgia and Fatigue Centers. He is a diplomate, board examiner and fellowship lecturer for the American Board of Anti-Aging Medicine (ABAAM) and The Endocrinology Expert for America Online (AOL) Health. He is a founding director of the non-profit Bioidentical Hormone Initiative and a senior faculty member of the Bioidentical Hormone Institute.
With BHI Online's Education & Online Training you can be amongst the first to hear about landmark research, clinical insights benefits of bioidentical hormone & other therapies.
Read more...
BHI Online houses an archive of hormone-related citations for biomedical literature. Also provided are links to PubMed and the NCBI molecular biology resources.
Read more...
BHI Online strives to support healthcare professionals through webinars presented by leading experts in their respective fields.
Read more...
Join the conversation with BHI Online's forums aimed at providing information through communities.
Read more...
A selection of stories and articles making headlines in the field of Bioidentical Hormone therapies.
Read more...
Locate a BHRT doctor, submit an article or just say hello, we'd love to meet you.
Read more...